Topic Alzheimer’s Disease Collection of interviews, videos and articles related to Alzheimer's disease Mental Health 18 Oct, 2022 Read Time: 3 mins Congress highlights Article Highlights from ECNP 2022 – Day 2 – October 16th Welcome to Progress in Mind’s live coverage of ECNP 2022. The 35th Congress of the European College... Mental Health 28 Jun, 2022 Read Time: 3 mins Congress highlights Article Highlights from EAN 2022 — Day 4 — June 28th Welcome to Progress in Mind’s live coverage of EAN 2022. This 8th Congress of the European Academy of... Mental Health 27 Jun, 2022 Read Time: 3 mins Congress highlights Article Highlights from EAN 2022 — Day 3 — June 27th Welcome to Progress in Mind’s live coverage of EAN 2022. This 8th Congress of the European Academy of... Mental Health 26 Jun, 2022 Read Time: 3 mins Congress highlights Article Highlights from EAN 2022 — Day 2 — June 26th Welcome to Progress in Mind’s live coverage of EAN 2022. This 8th Congress of the European Academy of... Alzheimer's Disease 22 Mar, 2022 Read Time: 3 mins Congress highlights New perspectives on Alzheimer’s disease Alzheimer’s disease is not part of normal aging. It is a brain disorder and not all people with... Alzheimer's Disease 17 Mar, 2022 Read Time: 3 mins Congress highlights A simple test combination for identifying early Alzheimer’s disease Many people experience mild cognitive decline, but what is their risk of developing Alzheimer’s... Alzheimer's Disease 07 Dec, 2021 Read Time: 2 mins Congress highlights Memory Lapses, Mild Cognitive Impairment and Cognitive Enhancers In this engaging session from the 2021 virtual Neurological Association of South Africa (NASA)... Alzheimer's Disease 24 Jun, 2021 Read Time: 3 mins Satellite symposium Factors damaging brain health and increasing the risk of Alzheimer’s disease Knowing the factors that increase the risk of Alzheimer’s disease can help healthcare providers... Migraine, Alzheimer's Disease 23 Jun, 2021 Read Time: 2 mins Congress highlights Highlights from EAN 2021 — Day 4 Today, 22 June, Day 4 of the 7th Congress of the European Academy of Neurology – Vienna 2021, was the... Migraine, Alzheimer's Disease 22 Jun, 2021 Read Time: 2 mins Congress highlights Highlights from EAN 2021 — Day 3 Progress in Mind’s coverage of the 7th Congress of the European Academy of Neurology – Vienna 2021... Alzheimer's Disease 21 Jun, 2021 Read Time: 3 mins Congress highlights New more accessible and affordable techniques for identifying people at risk of Alzheimer’s disease In specialist clinics, cerebrospinal fluid biomarkers for Abeta1-42, Abeta1-40, tTau, and pTau or... Migraine, Alzheimer's Disease 20 Jun, 2021 Read Time: 2 mins Congress highlights Highlights from EAN 2021 — Day 2 The exciting live and connected virtual experience for presenters and attendees of the 7th Congress... Migraine, Alzheimer's Disease 19 Jun, 2021 Read Time: 3 mins Congress highlights Highlights from EAN 2021 — Day 1 Welcome to Progress in Mind’s live coverage of EAN 2021. This 7th Congress of the European Academy of... Alzheimer's Disease 09 Dec, 2020 Read Time: 2 mins Congress highlights Measuring tau accumulation and progression The ability of PET to map regional changes in tau pathology over time provides important insights... Alzheimer's Disease 25 Nov, 2020 Podcast Which populations are most vulnerable to Alzheimer’s disease and why? Read the full article here. Alzheimer's Disease, Parkinson's Disease 29 Oct, 2020 Read Time: 3 mins Congress highlights Gut bacteria may trigger Alzheimer’s disease The role of the gut and it’s microbiota in neurodegerenative diseases have gain a lot of attention... Mental Health 03 Oct, 2020 Read Time: 2 mins Congress highlights Brain health becomes a global priority For years, the massive burden of mortality and morbidity caused by neurological diseases was not... Alzheimer's Disease 12 Sep, 2020 Read Time: 2 mins Congress highlights TDP-43: a newly-recognized route to cognitive decline There is growing clinical interest in TDP-43 proteinopathy, a relatively recent and fast-moving area... Migraine, Alzheimer's Disease 01 Sep, 2020 Read Time: 3 mins Congress highlights Countries need to work together to tackle brain diseases WHO global initiatives and national treatment pathways are key to reducing the huge burden that... Alzheimer's Disease 18 Aug, 2020 Read Time: 2 mins Congress highlights Modulating the microbiome: a revolution in the making? Altering the intestinal flora can influence host immunity, neuro-inflammation, and the deposition of... Alzheimer's Disease 30 Jun, 2020 Read Time: 2 mins Congress highlights Study motivated by apathy Conversion from mild cognitive impairment to Alzheimer’s disease dementia is not related to the... Alzheimer's Disease 20 Jun, 2020 Read Time: 3 mins Congress highlights Early palliative care in progressive neurological diseases Neurologists are often dealing with chronic diseases that progress in severity. Palliative care... Alzheimer's Disease 19 Jun, 2020 Read Time: 3 mins Congress highlights Imaging advances diagnosis and staging in dementias Tau-PET imaging in the clinic is on the horizon and would complement amyloid-PET and structural and... Alzheimer's Disease 13 May, 2020 Read Time: 2 mins Congress highlights Further evidence of cognitive and health benefits extends lifestyle intervention The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)... Alzheimer's Disease, Parkinson's Disease 16 Apr, 2020 Read Time: 2 mins Article COVID-19 and Dementia: a conjunction of pandemics The complexities of preventing and managing infection are multiplied in people living with dementia.... Alzheimer's Disease 03 Apr, 2020 Read Time: 2 mins Congress highlights Plenty of key targets in the dynamic Alzheimer’s pipeline Far from running dry, the pipeline is well provided with agents in development for Alzheimer’s... Mental Health 22 Mar, 2020 What role should patients play in treatment decision making? Mental Health 14 Feb, 2020 Read Time: 3 mins Article Real-world evidence — raising organizational fluency through interactive learning techniques Real-world evidence (RWE) demonstrates long-term effectiveness and safety beyond the efficacy and... Alzheimer's Disease 23 Jan, 2020 Read Time: 3 mins Congress highlights Assessing and managing agitation associated with Alzheimer’s dementia Agitation is common among patients with Alzheimer’s disease (AD) and results in a range of behavioral... Mental Health 14 Nov, 2019 Read Time: 3 mins Congress highlights Can blue-depleted light decrease duration of psychiatric hospitalization? Novel light and sensor technologies have been installed in a new acute psychiatric unit in Norway to... Alzheimer's Disease 06 Sep, 2019 Read Time: 3 mins Congress highlights Is it time to test anti-tau interventions in patients with asymptomatic Alzheimer’s disease? The microtubule-associated protein tau is a major component of the neurofibrillary tangles (NFT) of... Alzheimer's Disease 06 Sep, 2019 Read Time: 3 mins Congress highlights The emerging relationship between plasma and brain amyloid-β — does it play a role in the pathogenesis in Alzheimer’s disease? Reliable plasma amyloid-β (Aβ) measurement is now possible using new highly sensitive techniques, and... Alzheimer's Disease 22 Jul, 2019 Read Time: 3 mins Congress highlights Is it time to test anti-tau interventions in patients with asymptomatic Alzheimer’s disease? The microtubule-associated protein tau is a major component of the neurofibrillary tangles (NFT) of... Alzheimer's Disease 10 Apr, 2019 Read Time: 4 mins Congress highlights Making ready for early AD diagnosis When disease-modifying therapy becomes available, screening for Alzheimer’s and its subsequent... Alzheimer's Disease 05 Apr, 2019 Read Time: 3 mins Congress highlights Encouraging immune response to AD: adjuvants, modifying the microbiome, and microglial rejuvenation Modulating central and peripheral innate immunity has potential in Alzheimer’s Disease. Following... Alzheimer's Disease 12 Mar, 2019 Read Time: 5 mins Article Taking a closer look at tau Our understanding of tau pathology, a critical component of Alzheimer’s Disease development, will... Alzheimer's Disease 28 Jan, 2019 Read Time: 3 mins Article Inside the black box: Unlocking the potential of big data in neurodegenerative diseases Big data, artificial intelligence and machine learning offer huge opportunities for the collection... Alzheimer's Disease 22 Jan, 2019 Read Time: 5 mins Article Could targeting the brain’s clearance systems be beneficial in Alzheimer’s Disease? Amyloid-beta (Aβ) accumulation in Alzheimer’s Disease (AD) may, in part, be due to an impairment in... Alzheimer's Disease 14 Jan, 2019 Read Time: 3 mins Congress highlights The many faces of tau offer multiple targets for intervention in Alzheimer’s disease Tau is a complex, multifaceted target, implicated in many mechanisms involved in the pathology of... Mental Health 14 Jan, 2019 Read Time: 3 mins Congress highlights Mutual benefits: Public–Private Partnerships in CNS Research Public–Private Partnerships are being developed worldwide to facilitate collaboration between... Alzheimer's Disease, Parkinson's Disease 14 Jan, 2019 Read Time: 3 mins Congress highlights Gut bacteria may trigger Alzheimer’s disease The role of the gut and it’s microbiota in neurodegerenative diseases have gain a lot of attention... Alzheimer's Disease 27 Oct, 2018 Read Time: 4 mins Congress highlights It’s in the blood – identification of plasma biomarkers brings hope for screening and early detection of Alzheimer’s disease The recent discovery and validation of blood biomarkers offers huge potential for the early... Alzheimer's Disease 22 Oct, 2018 Read Time: 4 mins Article New insights into Apolipoprotein E and Alzheimer’s Disease Apolipoprotein E4 is a major risk factor for Alzheimer’s Disease and is strongly related to the... Mental Health 09 May, 2018 Read Time: 3 mins Congress highlights Investing in recovery – translating intervention into action You would think that the behaviour of a flock of starlings would have little to do with mental health... Alzheimer's Disease 09 May, 2018 Read Time: 3 mins Congress highlights Essential elements for Alzheimer’s disease clinical trials Stronger links between novel agents and their targets, more precise selection of patients, and better... Alzheimer's Disease 09 May, 2018 Read Time: 4 mins Congress highlights Could astrocyte activation initiate AD pathology 20 years before diagnosis? Neuroimaging techniques demonstrate a 20-year pathophysiological pathway preceding the development of... Alzheimer's Disease 09 May, 2018 Read Time: 4 mins Congress highlights Dietary interventions that may lower the risk of Alzheimer’s disease Increasing evidence shows that dietary interventions may lower the risk of developing Alzheimer’s... Mental Health 08 May, 2018 Read Time: 4 mins Congress highlights Updating DSM-5 to improve diagnostic validity and reliability and clinical utility Clinicians and researchers are invited to submit proposals for revisions to the fifth edition of the... Load More Most Popular
